ZBH
ZIMMER BIOMET HOLDINGS, INC.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Apr 28 ▲ Zimmer Biomet reported Q1 2026 adjusted EPS of $2.09, beating consen…
- May 1 to May 15 ▼ 2 sells: Ro Khanna sold $1,001 - $15,000, last disclosed Jun 11
- May 14 to May 27 ▲ 2 buys: Ro Khanna bought $1,001 - $15,000, last disclosed Jun 11
- May 29 ▼ 1 insider sell $413.2K at $82.64
- Jul 6 to Jul 23 ▼ 3 sells: Ro Khanna sold, last disclosed Aug 12
- Sep 2 Morrison v. Zimmer Biomet Holdings Inc et al
- Sep 4 to Sep 11 ▼ 2 days of insider sells: $824.0K by 2 insiders, avg $94.81
- Sep 11 to Sep 14 ▼ 2 sells: Ro Khanna sold $1,001 - $15,000, last disclosed Oct 9
- Sep 30 ▲ 4 funds open new positions (13F)
- Oct 7 Barclays initiates
- Oct 30 ▼ Ro Khanna sold $1,001 - $15,000, last disclosed Nov 9
- Nov 4 ▼ Earnings: ZBH Q3 2026 Earnings: EPS $1.9 (-0.1% vs est)
Signal stack
Where each data set points today.
- InsidersBEARISH
3 insiders sold $1.2M.
- InstitutionsMIXED
Q3 2026: 39 added (4 new), 35 trimmed or exited. Largest new: Qube Research & Technologies $16.3M.
- AnalystsMIXED
10 of 31 rate it Buy or better.
- Short sellersSTEADY
Short interest −1.4% to 7.85M shares. 3.9 days to cover, ≈4.2% of shares.
- TrendUPTREND
6% above its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | $214.4M |
| UBS Group AG | TRIM | $100.2M |
| Amundi | ADD | $87.6M |
| Alberta Investment Management Corp | ADD | $48.9M |
| FIRST TRUST ADVISORS LP | ADD | $48.3M |
| CAUSEWAY CAPITAL MANAGEMENT LLC | TRIM | $36.7M |
| JANE STREET GROUP, LLC | DOUBLED | $36.2M |
| CITIGROUP INC | ADD | $35.6M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
31 analysts| Date | Firm | Rating |
|---|---|---|
| Nov 16, 2026 | 🔒 Fresh data, subscribers only MAINTAIN | |
| Nov 16, 2026 | 🔒 Fresh data, subscribers only MAINTAIN | |
| Nov 9, 2026 | Barclays MAINTAIN | Equal-Weight |
| Nov 5, 2026 | UBS MAINTAIN | Buy |
| Nov 5, 2026 | JP Morgan MAINTAIN | Neutral |
| Nov 5, 2026 | Citigroup MAINTAIN | Neutral |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Campbell Gary Craig President, Americas Oct 1, 2026 | EXERCISE | 2,368 sh |
Campbell Gary Craig President, Americas Oct 1, 2026 | EXERCISE | 1,218 sh |
Campbell Gary Craig President, Americas Oct 1, 2026 | TAX W/H | $82.4K |
Campbell Gary Craig President, Americas Oct 1, 2026 | TAX W/H | $42.4K |
Hilado Maria Teresa Director Sep 30, 2026 | AWARD | 375.626 sh |
Farrell Michael J. Director Sep 30, 2026 | AWARD | 417.363 sh |
Kurdikar Devdatt Director Sep 30, 2026 | AWARD | 173.901 sh |
HIGGINS ARTHUR J Director Sep 30, 2026 | AWARD | 306.066 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
17 filings · 2 bullish · 2 bearish · 13 neutral- NEUTRAL 8-KNov 12, 2026
Zimmer Biomet completed two concurrent debt offerings on November 12, 2026: EUR 500 million of…
The refinancing addresses upcoming maturities (EUR 500M Dec 2026 and $600M Feb 2027) and extends the company's debt maturity profile. Monitor the Q4 2026 earnings for updated leverage ratios and any…
- NEUTRAL 424B5Nov 9, 2026
Zimmer Biomet is issuing $500M of 5.850% senior notes due 2036 in an underwritten debt offering…
The debt refinancing extends maturities and addresses near-term maturities (Dec 2026 and Feb 2027). Monitor the concurrent euro note offering for completion and total combined proceeds. Watch for…
- NEUTRAL 424B5Nov 9, 2026
Zimmer Biomet is issuing EUR 500 million of 4.375% notes due 2033, with net proceeds of…
The offering refinances near-term maturities (EUR 500M Dec 2026 and $600M Feb 2027 notes) and extends debt maturity profile. Monitor use of proceeds for debt repayment versus share repurchases or…
- NEUTRAL 424B5Nov 5, 2026
Zimmer Biomet filed a preliminary prospectus supplement for an underwritten offering of senior…
Monitor the final pricing supplement for the aggregate principal amount, interest rate, and maturity. The concurrent euro notes offering and potential use of proceeds to refinance near-term…
All ZBH filing & press-release reports (17)
- 8-K reportNov 12, 2026
- 424B5 reportNov 9, 2026
- 424B5 reportNov 9, 2026
- 424B5 reportNov 5, 2026
- 424B5 reportNov 5, 2026
- 8-K reportNov 4, 2026
- INST-CLUSTER reportOct 26, 2026
- COURT-RULING reportOct 21, 2026
- CLUSTER reportSep 15, 2026
- COURT-RULING reportSep 2, 2026
- COURT-RULING reportAug 17, 2026
- 8-K reportAug 5, 2026
- 8-K reportMay 12, 2026
- COURT-RULING reportMay 1, 2026
- 8-K reportApr 28, 2026
- 8-K reportApr 28, 2026
- DEFA14A reportApr 1, 2026